← back to search

Yimei Li

University of Colorado Denver · US
Area of research
Neurology · Public Health, Environmental and Occupational Health
Research interest
Research interests include Neuroblastoma Research and Treatments, Acute Lymphoblastic Leukemia research, Childhood Cancer Survivors' Quality of Life, and Neutropenia and Cancer Infections.
h-index
44
citations
7,090
works
537
NIH funding
primary concept
Medicine
email

Recent publications

Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies
Nature Medicine 2025cited by 68position: middledoi
Real-world generalizability of clinical trial cytomolecular risk in pediatric acute myeloid leukemia: a report from the REAL-AML cohort
JNCI Journal of the National Cancer Institute 2025cited by 0position: middledoi
Initiation of ACE inhibitors or beta-blockers during frontline therapy for pediatric Acute Myeloid Leukemia and the impacts on cardiotoxicity incidence and survival outcomes: A target trial emulation
Blood 2025cited by 0position: middledoi
Early cardiotoxicity and survival in pediatric Acute Myeloid Leukemia: The mediating roles of relapse and salvage chemotherapy intensity
Blood 2025cited by 0position: middledoi
Real-world post-relapse survival outcomes in children with Acute Myeloid Leukemia by race and ethnicity
Blood 2025cited by 0position: middledoi
Optimization of induction chemotherapy in pediatric patients with Acute Myeloid Leukemia: Real-world evidence to support removal of etoposide from induction 1
Blood 2025cited by 0position: middledoi
Photothermally enhanced antibacterial wound healing using albumin-loaded tanshinone IIA and IR780 nanoparticles
Frontiers in Bioengineering and Biotechnology 2024cited by 14position: middledoi
Providing Groceries and Transportation to Poverty-Exposed Pediatric Oncology Families
JAMA Network Open 2024cited by 11position: middledoi
Climate, demography, immunology, and virology combine to drive two decades of dengue virus dynamics in Cambodia
Proceedings of the National Academy of Sciences 2024cited by 11position: middledoi
Risk of Cardiovascular Events Among Patients With Head and Neck Cancer
JAMA Otolaryngology–Head & Neck Surgery 2023cited by 25position: middledoi
Outcomes After Nonresponse and Relapse Post-Tisagenlecleucel in Children, Adolescents, and Young Adults With B-Cell Acute Lymphoblastic Leukemia
Journal of Clinical Oncology 2022cited by 72position: middledoi
Progression-Free Survival and Patterns of Response in Patients With Relapsed High-Risk Neuroblastoma Treated With Irinotecan/Temozolomide/Dinutuximab/Granulocyte-Macrophage Colony-Stimulating Factor
Journal of Clinical Oncology 2022cited by 42position: middledoi
Reduced ER–mitochondria connectivity promotes neuroblastoma multidrug resistance
The EMBO Journal 2022cited by 30position: middledoi
Integrated molecular and clinical analysis of low-grade gliomas in children with neurofibromatosis type 1 (NF1)
Acta Neuropathologica 2021cited by 69position: middledoi
Medical Outcomes, Quality of Life, and Family Perceptions for Outpatient vs Inpatient Neutropenia Management After Chemotherapy for Pediatric Acute Myeloid Leukemia
JAMA Network Open 2021cited by 19position: middledoi
Idiopathic granulomatous mastitis with normal prolactin level caused by risperidone
Asian Journal of Surgery 2021cited by 7position: lastdoi
LGG-06. COMPREHENSIVE GENOMIC CHARACTERIZATION AND INTEGRATED CLINICAL ANALYSIS OF LOW-GRADE GLIOMAS IN CHILDREN WITH NEUROFIBROMATOSIS TYPE 1
Neuro-Oncology 2021cited by 0position: middledoi
Broad-Spectrum Antibiotics and Risk of Graft-versus-Host Disease in Pediatric Patients Undergoing Transplantation for Acute Leukemia: Association of Carbapenem Use with the Risk of Acute Graft-versus-Host Disease
Transplantation and Cellular Therapy 2020cited by 26position: middledoi
Clinical risks and healthcare utilization of hematopoietic cell transplantation for sickle cell disease in the USA using merged databases
Haematologica 2017cited by 60position: middledoi
CASC15-S Is a Tumor Suppressor lncRNA at the 6p22 Neuroblastoma Susceptibility Locus
Cancer Research 2015cited by 181position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Kelly Getz · Pediatrics and Genetics3 papers (2021–2025)Kira Bona · Boston Children's Hospital3 papers (2021–2025)Rajen Mody · Homi Bhabha National Institute3 papers (2021–2025)Richard Aplenc · University College London2 papers (2021–2025)Jennifer J. Wilkes · Seattle Children's Hospital2 papers (2021–2025)M. Monica Gramatges · Baylor College of Medicine2 papers (2021–2025)Kelly W. Maloney · Children's Hospital Colorado2 papers (2021–2025)Catherine Aftandilian · Palo Alto University2 papers (2021–2025)Javed Khan · University of Science and Technology Bannu1 papers (2015–2015) · 1 papers (2022–2022)Chaoqun Ma · Nanjing University of Chinese Medicine1 papers (2024–2024)Anupam Verma · University of Maryland, Baltimore1 papers (2021–2021)Julie Wolfson · University of Alabama at Birmingham1 papers (2024–2024)Haidong Chen · Nanjing University of Chinese Medicine1 papers (2024–2024) · 1 papers (2024–2024)Michelle Choe · Seattle Children's Hospital1 papers (2022–2022) · 1 papers (2022–2022)Keri A. Streby · The Ohio State University1 papers (2022–2022)Elizabeth A. Raetz · NYU Langone Health1 papers (2021–2021) · 1 papers (2022–2022)